Shares of Infinity Pharmaceuticals ($INFI@US) are trading higher on Monday mornings after the company recently announced that they received patent specification for their “Heterocyclic Compounds And Uses Thereof” by the European Union. Shares of Infinity are up 7.6 at press time.